Medtronic (NYSE:MDT) will reportedly be adding 200 research and development positions in Galway, Ireland.
According to a report in The Independent, the medtech giant has already filled more than half of the R&D roles, which come as part of a $30 million investment.
“These roles will support the development of products and services in the coronary artery, heart valve and peripheral vascular disease, heart arrhythmia and pacing, hypertension and spinal injury areas,” Gerard Kilcommins, Medtronic VP of global manufacturing, vascular therapies and implants and country director told The Independent.
Other jobs in the areas of chemical analysis and biocompatibility for supporting Medtronic’s global laboratory services team will also be available, the report said. The 200 new jobs add to approximately 4,000 employees already operating across Ireland, where the company’s corporate headquarters are located (Dublin).
The company is marking 40 years in Ireland as well.
“The 40-year anniversary is an important milestone to celebrate in Medtronic’s Irish story. Our sites in Ireland have played a significant role in Medtronic’s evolution from medical device manufacturer to a global leader in healthcare technology,” Kilcommins added, according to the report.